Pharmaceutical Company Rankings by Equity ratio

Compare Japanese listed companies using EDINET financial data across metrics such as revenue, margins, ROE, and growth.

For Pharmaceutical by Equity ratio, the top 5 companies are ノイルイミューン・バイオテック株式会社 (97.8%), RIBOMIC Inc. (95.4%), 株式会社Veritas In Silico (94.6%), Renascience Inc. (94.5%), Heartseed株式会社 (93.7%). 81 of 82 companies in the selected population have usable Equity ratio data. The ranking uses each company’s latest annual data; fiscal periods may differ. Companies ranked sixth and below are also shown in the ranking table below.

Compare industries by Median Equity Ratio
Selected industries

Ranking metrics

Company ranking table

No companies selected

Company ranking table
Rank Company Industry Fiscal year Equity ratio
1 ノイルイミューン・バイオテック株式会社 Pharmaceutical FY2025 97.8%
2 RIBOMIC Inc. Pharmaceutical FY2026 95.4%
3 株式会社Veritas In Silico Pharmaceutical FY2025 94.6%
4 Renascience Inc. Pharmaceutical FY2026 94.5%
5 Heartseed株式会社 Pharmaceutical FY2026 93.7%
6 Modalis Therapeutics Corporation Pharmaceutical FY2025 93.0%
7 株式会社メドレックス Pharmaceutical FY2025 92.2%
8 TMS Co., Ltd Pharmaceutical FY2025 92.1%
9 Cuorips Inc. Pharmaceutical FY2026 91.6%
10 Kubota Pharmaceutical Holdings Co., Ltd. Pharmaceutical FY2025 91.6%

Select industries

Search by industry name and select one or more.

No industries selected

Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.